John S. Montalbano

Director at AbCellera Biologics · 3 reported transactions in 1 company · latest trade Aug 18, 2026

Their record

Across their whole record, 1 purchase can be measured; 1 did better than the S&P 500 over the next 6 months.

Typical move +41.2%, S&P 500 +9.3% over the same days.

1 more is too recent to measure.

Their trades


AbCellera BiologicsABCL	Bought $110.3K · 10,000 shares	Aug 18, 2026	S&P 500 −0.3%thru Oct 26
AbCellera BiologicsABCL	Bought $95.4K · 20,000 shares	May 14, 2026	S&P 500 +2.3%thru Oct 26
AbCellera BiologicsABCL	Bought $178.5K · 50,000 shares	Nov 26, 2025	S&P 500 +12.6%thru Oct 26

BoughtAbCellera Biologics

Aug 18, 2026 · ABCL

$110.3K

S&P 500 −0.3%thru Oct 26

BoughtAbCellera Biologics

May 14, 2026 · ABCL

$95.4K

S&P 500 +2.3%thru Oct 26

BoughtAbCellera Biologics

Nov 26, 2025 · ABCL

$178.5K

S&P 500 +12.6%thru Oct 26

3 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.